secwatch.observer — SEC 8-K summary
======================================

Issuer:     XFLH Capital Corp (XFLH)
CIK:        0002088103
Form:       8-K
Filed at:   2026-09-22T12:30:22+00:00
Accession:  0001185185-26-004190
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XFLH Capital signs non-binding LOI to combine with Renogen Biolab
-----------------------------------------------------------------

- On Sept 18, 2026, XFLH Capital entered a non-binding letter of intent for a business combination with Renogen Biolab Inc., a Canadian health service provider.
- Renogen Biolab offers DNA services, vector engineering, and protein expression; parties will negotiate definitive agreements with due diligence access.
- No deal value, premium, or closing conditions disclosed; the LOI is non-binding and subject to negotiation of Definitive Agreements.
- XFLH is a Cayman Islands blank-check SPAC; its units, ordinary shares, and rights trade on NYSE under XFLHU, XFLH, XFLHR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2088103/000118518526004190/0001185185-26-004190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2088103/000118518526004190/xflh8k021326.htm
  HTML page:      https://secwatch.observer/filing/0001185185-26-004190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer